Guideline Atlas

Deep vein thrombosis

Also known as: DVT · VTE

Also relevant to Hematology & Oncology

Free to read — no account needed. Sign in only to bookmark this disease and track your study progress.

United StatesACC/AHA
Current

Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report (2021)

CHEST (ACCP) · 2021 · 2021 (Second Update)

The current US antithrombotic-therapy guidance for venous thromboembolism, from the American College of Chest Physicians. It updates the 2016 CHEST guideline.

  • Recommends direct oral anticoagulants over vitamin K antagonists for VTE without associated cancer. source
  • Frames therapy as an initiation phase, a 3-month treatment phase, and an extended phase for selected patients. source
Verify against original ↗
EuropeESC

No ESC guideline indexed for this condition yet.

Every entry is added by hand and cited to the issuing society, so a gap here means we have not verified one — not that none exists. Know the right one? Tell us.

US vs EU key differences

No curated US/EU comparison yet for this disease.

What changed recently

  1. US2016 (First Update) → 2021 (Second Update)2021-08-02

    The second CHEST update revises the 2016 VTE guideline with four new questions and eight substantially modified statements, and defines anticoagulation phases explicitly - an initiation phase of about 5 to 21 days followed by a treatment phase of roughly 12 weeks - to structure decisions on drug choice and duration.

    source ↗curation confidence 90%

See the full update feed for changes across every system.